Case report reveals occlusive vasculitis in a patient, suggesting workup for Good Syndrome in similar cases.
Purpose: To introduce an atypical occlusive panretinal vasculitis without necrotizing retinitis secondary to cytomegalovirus (CMV) infection as the heralding clinical event for a patient ultimately discovered to have Good Syndrome, a systemic immunodeficiency. Methods: Case report. Results: A 77-year-old male with a history of hypertension, diabetes mellitus, recurrent sinusitis, and oral thrush presented with 3 weeks of headaches and vision loss (20/250) in the right eye. Examination revealed panuveitis, scattered mid-peripheral intraretinal hemorrhages without retinal necrosis, profound retinal vascular nonperfusion, and elevated IOP due to anterior segment neovascularization. Aqueous humor viral PCR analysis revealed a high CMV viral load. Systemic evaluation was negative for HIV, CMV, toxoplasmosis, and syphilis; carotid duplex imaging was normal, leukemia and lymphoma studies were negative; and he was not neutropenic. CD4+ count and immunoglobulin levels were decreased, suggesting a combined B- and T-cell immunodeficiency. Computed tomography of the chest revealed a thymoma, consistent with Good Syndrome, a rare immunocompromising condition. Antiviral therapy did not significantly reverse retinal perfusion. Conclusion: Panretinal occlusive vasculitis without retinal necrosis is a rare phenotype of CMV retinitis. In HIV-negative patients with CMV retinitis, additional immunodeficiency workup is required, and rare combined immunodeficiencies such as Good Syndrome should be included on the differential.
No takes yet. Share an insight, caveat, or question.
Rajesh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: